featured
Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients
J. Clin. Oncol 2020 Sep 16;[EPub Ahead of Print], M Sawaki, N Taira, Y Uemura, T Saito, S Baba, K Kobayashi, H Kawashima, M Tsuneizumi, N Sagawa, H Bando, M Takahashi, M Yamaguchi, T Takashima, T Nakayama, M Kashiwaba, T Mizuno, Y Yamamoto, H Iwata, T Kawahara, Y Ohashi, H MukaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.